### 1 

### Appendix 5: Detailed Ri sk Modeling Results

### 2 Table 1 - Facility Identification Information

Source

Category Facility NEI ID Facili ty Name Address City State

Secondary Lead NEI117 EAST PENN MFG CO

INC/SMELTER PLT DEKA RD PO BOX 147 LYON STATION PA

Secondary Lead NEI18383 SANDERS LEAD CO 100 SANDERS RD TROY AL

Secondary Lead NEI21201 QUEMETCO INC 720 S 7TH AV INDUSTRY CA

Secondary Lead NEI26338 GULF COAST RECYCLING, INC. 1901 N 66TH STREET TAMPA FL

Secondary Lead NEI2CA124838 EXIDE CORPORATION 2700 SOUTH INDIANA

STREET VERNON CA

Secondary Lead NEI31400 EXIDE TECHNOLOGIES 2601 WEST MT

PLEASANT BLVD MUNCIE IN

Secondary Lead NEI32182 QUEMETCO, INC. 7870 W. MORRIS

STREET INDIANAPOLIS IN

Secondary Lead NEI34021 GOPHER RESOURCE CORP 3385 S HIGHWAY 149 EAGAN MN

Secondary Lead NEI34270 EXIDE TECHNOLOGIES-CANON

HOLLOW PLANT 111 CANON HOLLOW

ROAD FOREST CITY MO

Secondary Lead NEI38394 REVERE SMELTING & REFINING

CORP 65 BALLARD RD MIDDLETOWN NY

Secondary Lead NEI40662 EXIDE TECH/READING SMELTER 2ND & WASHINGTON

ST READING PA

Secondary Lead NEI6493 FRISCO BATTERY RECYCLI NG 7471 S FIFTH ST FRISCO TX

Secondary Lead NEILAT$10672 EXIDE TECHNOLOGIES/B R

SMELTER 2400 BROOKLAWN DR BATON ROUGE LA

Secondary Lead NEIPR01300001 BATTER Y RECYCLING CO. ROAD 2 KM 72.2,

CAMBALACHE

WARD/PO BOX 1016 ARECIBO PR

Secondary Lead NEIMO0930005 DOE RUN COMPANY-BUICK MILL HIGHWAY KK BOSS MO3Table2–MaximumPredictedHEM‐3ChronicRisks1BOLDindicatesacancerriskgreaterthan1inamillionoranoncancerriskgreaterthan1CancerMIRCancerIncidenceNoncancerMax HITargetOrganCancerMIRCancerIncidenceNoncancerMax HITargetOrganNEI1171.87E‐067.42E-050.02developmental1.62E‐066.91E-050.02developmentalNEI183835.11E‐056.21E-040.62kidney3.99E‐061.75E-040.12respiratoryNEI212014.48E‐061.09E-030.06kidney4.48E‐061.09E-030.06kidneyNEI263389.46E‐061.66E-030.10developmental2.35E‐061.10E-030.06respiratoryNEI2CA1248385.58E‐066.69E-030.07kidney2.35E‐063.72E-030.03developmentalNEI314001.55E‐061.35E-040.02developmental6.28E‐077.92E-050.01developmentalNEI321821.92E‐067.94E-040.03developmental1.88E‐067.84E-040.03developmentalNEI340211.11E‐055.61E-040.14kidney2.36E‐062.56E-040.03kidneyNEI342703.84E‐062.53E-050.07respiratory1.73E‐061.89E-050.06respiratoryNEI383947.34E‐063.92E-040.10developmental7.19E‐063.89E-040.10developmentalNEI406623.28E‐059.93E-040.40developmental6.22E‐063.34E-040.09developmentalNEI64931.20E‐051.76E-030.14developmental5.12E‐061.04E-030.13respiratoryNEILAT$10672 1.18E‐066.60E-040.02respiratory4.53E‐073.31E-040.01respiratoryNEIMO09300053.41E‐056.61E-040.41developmental2.37E‐068.13E-050.03developmentalNEIPR013000016.09E‐061.57E-040.07kidney6.27E‐074.02E-050.01developmentalFacility NEI IDSource Category Chronic Risk (Baseline)1Source Category Chronic Risk (Post-control)1

### 4 Table 3 – Maximum Predicted Acute Risks by Facility

Facility NEI ID Pollutant Criteria HEM-3

(Screening)

(Baseline) HEM-3

(Screening)

(Controlled) Refined

Results 1

(Controlled)

NEI117 Arsenic compounds REL 0.4 0.4

NEI18383 Arsenic compounds REL 4 0.3

NEI21201 Arsenic compounds REL 0.4 0.4

NEI26338 Arsenic compounds REL 0.6 0.3

NEI2CA124838 Arsenic compounds REL 2 0.9

NEI31400 Arsenic compounds REL 0.8 0.3

NEI32182 Arsenic compounds REL 1 1

NEI34021 Arsenic compounds REL 1 0.3

NEI34270 Arsenic compounds REL 2 0.2

NEI38394 Arsenic compounds REL 5 5 5

NEI40662 Arsenic compounds REL 2 0.7

NEI6493 Arsenic compounds REL 3 1

NEIPR01300001 Arsenic compounds REL 2 0.1

NEILAT$10672 Arsenic compounds REL 20 8 1

NEIMO0930005 Arsenic compounds REL 20 2 2

1 Facilities with a HEM-3 screening controlled value great er than 1 were refined by examining results for

maximum off-site impacts, see Appendix 6 for figures depi cting off-site impacts. All results in Table 3 are

presented to 1 significant figure

### 5 Table 4 – Maximum Predicted Lead Risks by Facility

Facility NEI ID Concentration

is X times

higher than

the NAAQS

(Baseline) Concentration

is X times

higher than

the NAAQS

(Controlled)

NEI117 0.1 0.1

NEI18383 10 0.7

NEI21201 1 1

NEI26338 3 0.2

NEI2CA124838 8 3

NEI31400 1 0.2

NEI32182 0.5 0.4

NEI34021 2 0.5

NEI34270 3 0.2

NEI38394 0.7 0.6

NEI40662 2 0.4

NEI6493 2 0.2

NEILAT$10672 0.9 0.2

NEIPR01300001 5 0.3

NEIMO0930005 20 0.8



### *Results presented to 1 significant figure

### 6 Table 5

‐ MACT allowable MIR (also see allowable MIR and TOSHI excel spreadsheet in the rulemaking

docket)

Facility Name: Allowable

Scaling

Factor MACT Allowable MIR

Exide, Reading, PA 10.6 5.34301E

‐ 05

Frisco, Frisco, TX 7.4 6.35729E

‐ 05

Doe Run, Boss, MO 2.5 4.1641E

‐ 05

Gulf Coast, Tampa, FL 9.9 2.09662E

‐ 05

RSR, Middletown, NY 32.2 1.81E

‐ 04

Exide, Forest City, MO 17.9 2.67712E

‐ 05

Quemetco, Indianapolis, IN 56.5 7.49044E

‐ 05

East Penn, PA 34.8 1.83661E

‐ 05

Exide, Muncie, IN 95.3 2.87499E

‐ 05

Exide, Baton Rouge, LA 2.7 2.06959E

‐ 06

* MACT allowable risk was calculated by applying the allowable scaling factor to stack emissions

on a stack by stack basis. Only facilities with stack emissions are presented in this table